Connection

Jeffrey Hammerbacher to Antigens, Neoplasm

Back to Details
This is a "connection" page, showing publications Jeffrey Hammerbacher has written about Antigens, Neoplasm.
Jeffrey Hammerbacher
Connection Strength
1.269
Antigens, Neoplasm
  1. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer. 2018 01 22; 18(1):87.
    View in: PubMed
    Score: 0.557
  2. Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. Cancer Immunol Res. 2017 01; 5(1):84-91.
    View in: PubMed
    Score: 0.516
  3. Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy. Oncology (Williston Park). 2015 12; 29(12):970-2, 974-5.
    View in: PubMed
    Score: 0.120
  4. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction. Immunity. 2019 10 15; 51(4):766-779.e17.
    View in: PubMed
    Score: 0.039
  5. Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Rep. 2018 12 26; 25(13):3721-3732.e6.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.